PAVmed Inc. (PAVM) to Release Earnings on Thursday

PAVmed Inc. (NASDAQ:PAVM) will be releasing its earnings data after the market closes on Thursday, November 16th. Analysts expect PAVmed to post earnings of ($0.16) per share for the quarter.

PAVmed (NASDAQ:PAVM) last announced its quarterly earnings data on Monday, August 14th. The company reported ($0.13) earnings per share for the quarter, beating the consensus estimate of ($0.14) by $0.01. On average, analysts expect PAVmed to post $-1 EPS for the current fiscal year and $0 EPS for the next fiscal year.

PAVmed Inc. (PAVM) opened at $4.00 on Friday. PAVmed Inc. has a twelve month low of $2.54 and a twelve month high of $12.10.

Several brokerages have weighed in on PAVM. ValuEngine lowered PAVmed from a “sell” rating to a “strong sell” rating in a report on Friday, July 28th. Dawson James reaffirmed a “buy” rating and issued a $10.10 price target on shares of PAVmed in a report on Tuesday, September 5th.

In related news, CFO Dennis M. Mcgrath purchased 6,000 shares of the business’s stock in a transaction dated Tuesday, August 22nd. The stock was purchased at an average cost of $4.21 per share, with a total value of $25,260.00. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Insiders bought 15,835 shares of company stock valued at $63,816 over the last ninety days. Corporate insiders own 79.30% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “PAVmed Inc. (PAVM) to Release Earnings on Thursday” was originally published by StockNewsTimes and is the property of of StockNewsTimes. If you are reading this piece on another site, it was copied illegally and republished in violation of U.S. and international copyright laws. The correct version of this piece can be read at

About PAVmed

PAVmed Inc operates as a medical device company in the United States. Its product pipeline includes PortIO, a long-term implantable vascular access device; CarpX, a percutaneous device to treat carpal tunnel syndrome; NextCath, a self-anchoring catheter; DisappEAR: Antibiotic-eluting resorbable ear tube; NextFlo, a disposable infusion pump; and Caldus, a disposable tissue ablation device.

Receive News & Ratings for PAVmed Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PAVmed Inc. and related companies with's FREE daily email newsletter.

Latest News

Leave a Reply